Clarivate Plc · NYSE:CLVT
Clarivate — Conference Presentation (March 2024)
23 slides from Clarivate's conference presentation, March 2024
Slide 1: Clarivate in the Age of AI
Clarivate in the Age of AI Empowering our Life Sciences & Healthcare customers to create a healthier tomorrow
Slide 2: Safe Harbor Statement and Non-GAAP Financial Measures
Safe Harbor Statement and Non-GAAP Financial Measures Forward-Looking Statements This communication contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements, which express management's current views concerning future business, events,
Slide 3: Agenda
Agenda Introduction Life Sciences & Healthcare Overview Life Sciences & Healthcare Strategy Life Sciences & Healthcare Generative AI Strategy Generative AI Demos - Cortellis [] Q&A Conversational Search - Cortellis [] Flexible Attribute Extraction Closing Summary © 2024 Clarivate. All rights reserve
Slide 4: Introduction
Introduction 25+ years of leadership experience with deep expertise across Life Sciences research and development Joined Clarivate in April 2023 from Veeva Systems, a global leader in cloud software for the life sciences industry, serving as President, Global R&D and Quality, with responsibility for
Slide 5: Key takeaways from today's presentation
Key takeaways from today’s presentation 1 2 3 4 GenAI as a catalyst for Solutions at the center of Focused investments and Building a growth driving transformation in mission-critical decisions heightened innovation to acceleration engine with product mix to expand by our customers unlock whitespace
Slide 6: Life Sciences & Healthcare Overview
Life Sciences & Healthcare Overview
Slide 7: Enabling organizations to deliver safe, effective and commercially successful treatments
Enabling Life Sciences & Healthcare organizations to deliver safe, effective and commercially successful treatments and solutions to patients faster Drive asset and Discover and advance Accelerate the path Measure, protect, portfolio value innovative candidates to patients improve outcomes Pct. of C
Slide 8: Contextual intelligence at the nexus of critical decisions
Contextual intelligence at the nexus of critical decisions, transforming the way our customers do business Corporate R&D Commercial Strategy | Business Dev. Discovery | Development Launch | Market Access | & Licensing | M&A | Regulatory & Safety Commercial Targeting Real World Data Expert Services A
Slide 9: Best-in-class data and expertise power our flagship brands and solutions
Best-in-class data and expertise power our flagship brands and solutions Corporate Research & Development Commercial Cortellis Drug Discovery Fingertip Formulary Cortellis Competitive Intelligence Cortellis Regulatory Healthbase Disease Landscape & Forecasting OFF-X MedTech 360 Drug Safety Triager R
Slide 10: Customer Video
Customer Video (5 Clarivate’ | © CLE® DIAGNOSTICS
Slide 11: Life Sciences & Healthcare Strategy
Life Sciences & Healthcare Strategy
Slide 12: On track to achieve market growth in 2026
On track to achieve market growth in 2026 Strategic Priorities (Market Growth ~8% 1) Modernizing Intelligence Platforms Life Sciences & Healthcare 19-22A 23A 24P 26T Prior Current Corporate R&D Driving Product ~17%2 Research & Development Innovation R&S Comm’l Commercial Investing in Real World Data
Slide 13: Realizing our growth opportunity in Life Sciences & Healthcare
Realizing our growth opportunity in Life Sciences & Healthcare Modernizing Intelligence Driving Investing in 1 2 3 Platforms Product Innovation Real World Data Making intelligence actionable Catalyzing synergistic capabilities Building a growth engine from through scalable next-generation to penetra
Slide 14: Making intelligence actionable through next-generation technologies
Making intelligence actionable through next-generation technologies Focus on core platforms enabled through AI Consolidating into scalable core platforms and leveraging AI to drive product quality and advanced analytics Evolve to workflow solutions Complementing our market intelligence with AI-infus
Slide 15: Catalyzing synergistic capabilities to unlock new value with customers
Catalyzing synergistic capabilities to unlock new value with customers Penetrate market white space Increasing our scale in attractive market segments with new products and penetrating further within existing accounts Maximize value from recent launches Significant runway for newer products within l
Slide 16: Building a growth engine from enriched, pharma-grade data products
Building a growth engine from enriched, pharma-grade data products Target life sciences end users Evolving our RWD business model toward tailored solutions and go-to- market for core pharma, biotech, and medtech customers Build therapy area franchises Focusing on differentiated therapy area and indi
Slide 17: Renewed operational focus and innovation-forward strategies fuel organic growth acceleration
Renewed operational focus and innovation-forward strategies fuel organic growth acceleration toward high single digits in FY26 1 2 3 Modernizing Driving Product Investing in Intelligence Platforms Innovation Real World Data Corporate All segments performing at or R&D near market growth rates Commerc
Slide 18: Life Sciences & Healthcare Generative AI Strategy
Life Sciences & Healthcare Generative AI Strategy
Slide 19: Generative AI has the potential to revolutionize R&D
Generative AI in Life Sciences & Healthcare has the potential to revolutionize R&D through commercialization and improve patient outcomes Significant appetite for adoption Our customers are increasingly focusing on leveraging Generative AI both across research and development and operational functio
Slide 20: Infusing Generative AI across our solutions to drive deeper value
Infusing Generative AI across our solutions to drive deeper value Advance Existing Transform with Increase Solutions Gen AI Efficiencies Embed Gen AI Innovate with new Unlock efficiencies for in current solutions solutions customers and Clarivate Cortellis RWD Insights AI Driven Business Process Por
Slide 21: Today's AI demonstrations
Today’s AI demonstrations Cortellis Q&A Cortellis Flexible Attribute Extraction Conversational Search AI-driven Contextual Insights © 2024 Clarivate. All rights reserved. 21
Slide 22: Closing Summary
Closing Summary
Slide 23: About Clarivate
About Clarivate © 2024 Clarivate Clarivate is the leading global information services provider. We connect people and organizations to intelligence they can trust to transform their Clarivate and its logo, as well as all other perspective, their work and our world. Our subscription and technology-ba